Latest News in the pharma Industry

Biopharma News

Regeneron and Sanofi announce sarilumab BLA Accepted for review by FDA

Regeneron and Sanofi announce sarilumab BLA Accepted for review by FDA

8 Jan 2016

Sarilumab is an investigational, human monoclonal antibody intended for the treatment of patients with active, moderate-to-severe rheumatoid arthritis

Read more 
AmpliPhi acquires key bacteriophage assets from UK-based Novolytics

AmpliPhi acquires key bacteriophage assets from UK-based Novolytics

8 Jan 2016

The assets will broaden AmpliPhi's IP portfolio and speed the development of its phage therapies

Read more 
Takeda acquires US biologics manufacturing facility

Takeda acquires US biologics manufacturing facility

6 Jan 2016

Takeda intends to use the facility primarily for the manufacture of Entyvio (vedolizumab) and other biologic products.

Read more 
Boehringer Ingelheim invests in Europe: pharma company expands biopharmaceutical production at Vienna site

Boehringer Ingelheim invests in Europe: pharma company expands biopharmaceutical production at Vienna site

26 Dec 2015

The total investment is around a half billion euro.

Read more 
Baxalta and Momenta announce M923, a proposed Humira biosimilar, met primary endpoint in pharmacokinetic study

Baxalta and Momenta announce M923, a proposed Humira biosimilar, met primary endpoint in pharmacokinetic study

23 Dec 2015

Read more 
BeiGene selects GE’s FlexFactory biomanufacturing platform for pilot cGMP production facility in China

BeiGene selects GE’s FlexFactory biomanufacturing platform for pilot cGMP production facility in China

16 Dec 2015

Facility will manufacture biologics for clinical trials.

Read more 
Quintiles launches suite of services to integrate asset development planning

Quintiles launches suite of services to integrate asset development planning

14 Dec 2015

New offering incorporates clinical, commercial and regulatory insight to improve the probability of an asset’s commercial success.

Read more 
ImmBio initiates First-in-Human studies of its novel pneumococcal vaccine, PnuBioVax

ImmBio initiates First-in-Human studies of its novel pneumococcal vaccine, PnuBioVax

11 Dec 2015

The PnuBioVax vaccine contains heat shock proteins and multiple antigens produced by a modified form of S. pneumoniae, leading to a mechanism of action which is expected to be strain-independent.

Read more 
AstraZeneca to harness power of the Secretome and develop next-generation biologics in collaboration with new WCPR

AstraZeneca to harness power of the Secretome and develop next-generation biologics in collaboration with new WCPR

11 Dec 2015

Read more 
Merck Announces Samsung Bioepis receives approval of Renfelxis (infliximab), a biosimilar of Remicade, in Korea

Merck Announces Samsung Bioepis receives approval of Renfelxis (infliximab), a biosimilar of Remicade, in Korea

7 Dec 2015

Samsung Bioepis’ second immunology biosimilar approved, to be commercialized under partnership with Merck

Read more 
Bespak addresses India’s biopharmaceutical drive for high value drug delivery products that differentiate generics, biobetters and biosimilars at CPhI India 2015

Bespak addresses India’s biopharmaceutical drive for high value drug delivery products that differentiate generics, biobetters and biosimilars at CPhI India 2015

3 Dec 2015

The company showcases the innovative Syrina 2.25 auto-injector that brings the flexibility to design a unique form factor and also the full Syrina platform accommodating multiple primary containers and high viscous, high volume injections.

Read more 
Novozymes' Veltis half-life extension technology embraced by Paras Biopharmaceuticals to develop new biobetter

Novozymes' Veltis half-life extension technology embraced by Paras Biopharmaceuticals to develop new biobetter

30 Nov 2015

Paras Biopharmaceuticals partners with Novozymes in a feasibility study using Veltis technology to develop an improved version of a leading osteoporosis treatment.

Read more